Report on the international symposium on Hepatitis E, Seoul, South Korea, 2010

Emerging Infectious Diseases

Volumn 18, Issue 5, 2012, Pages

  Wierzba, Thomas F ^a   Panzner, Ursula ^a  

^a International Vaccine Institute   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HEV 239; RECOMBINANT HEPATITIS E VIRUS VACCINE; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ARTICLE; DISEASE TRANSMISSION; FATALITY; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; HYGIENE; PUBLIC HEALTH PROBLEM; RISK FACTOR; SANITATION; SOUTH KOREA;

HEPATITIS E; HUMANS; REPUBLIC OF KOREA;

EID: 84859865358     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1805.111916     Document Type: Article

References (6)

1. Aggarwal R. Hepatitis E: historical, contemporary and future perspectives. J Gastroenterol Hepatol. 2011;26(Suppl 1):72-82.
2. Khuroo MS. Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med. 1980;68:818-24.
3. Wong DC, Purcell RH, Sreenivasan MA, Prasad SR, Pavri KM. Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus aetiology. Lancet. 1980;316:876-9.
4. Lu L, Li C, Hagedorn CH. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol. 2006;16:5-36.
5. Krawczynski K, Hepatitis E. Hepatology. 1993;17:932-41.
6. Labrique A, Kuniholm M, Nelson K. The global impact of hepatitis E-new horizons for an emerging virus. In: Scheld W, Murray B, Hughes J, editors. Emerging infections. Washington (DC): ASM Press; 2010; 53-94.